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Physiology and Biochemistry
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nnnn The purpose of this study was to determine the effects of
oral creatine supplementation on high intensity, intermittent ex-
ercise performance in competitive squash players. Nine squash
players (mean  SEM VÇO2max = 61.9  2.1ml ´ kg±1 ´ min±1; body
mass = 73  3 kg) performed an on-court ªghostingº routine that
involved 10 sets of 2 repetitions of simulated positional play,
each set interspersed with 30 s passive recovery. A double blind,
crossover design was utilised whereby experimental and control
groups supplemented 4 times daily for 5 d with 0.075 g ´ kg±1
body mass of creatine monohydrate and maltodextrine, respec-
tively, and a 4 wk washout period separated the crossover of
treatments. The experimental group improved mean set sprint
time by 3.2  0.8 % over and above the changes noted for the
control group (P = 0.004 and 95 % Cl = 1.4 to 5.1 %). Sets 2 to 10
were completed in a significantly shorter time following creatine
supplementation compared to the placebo condition (P < 0.05).
In conclusion, these data support existing evidence that creatine
supplementation improves high intensity, intermittent exercise
performance. In addition, the present study provides new evi-
dence that oral creatine supplementation improves exercise per-
formance in competitive squash players.
n Key words: Phosphocreatine, ergogenic aid, repetitive
sprint, ghosting.
Introduction
Squash rackets is a game characterised by repeated bouts of
high intensity exercise which place considerable demands on
both the aerobic and anaerobic energy systems [36, 44]. Phos-
phocreatine (PCr) is one of the most important substrates for
adenosine triphosphate (ATP) resynthesis during the high
intensity exercise bouts and it is generally accepted that the
development of fatigue during maximal short duration exer-
cise is associated with the depletion of muscle PCr stores
[16,26, 30,35]. Creatine (Cr) and PCr serve to continuously pre-
serve intracellular ATP availability, modulate metabolism and
buffer hydrogen ion accumulation during muscle contraction
[21].
Athletes have used Cr supplementation in an attempt to in-
crease the muscle PCr concentration and thereby improve ex-
ercise performance by delaying PCr depletion and the rate of
ADP accumulation during maximal exercise and/or promoting
PCr resynthesis during recovery. Several studies have reported
improved exercise performance in healthy individuals during
repeated bouts of maximal short-duration exercise following
Cr supplementation [2,5,23].
Most studies, however, claim an ergogenic effect of Cr on the
basis of laboratory based experimental protocols ± few studies
have examined the effects of Cr on exercise performance under
realistic competitive milieu. Furthermore, there is a paucity of
data regarding the effects of Cr on exercise performance in
well-trained individuals, and the authors are unaware of any
published research documenting the ergogenic potential of Cr
supplementation for improvement in squash-specific exercise
performance. The specific metabolic requirements of squash
lend themselves to the study of Cr supplementation on subse-
quent exercise performance. Thus, the purpose of the present
study was to conduct a placebo controlled, double blind cross-
over study to determine the effects of oral Cr supplementation
on high intensity, intermittent exercise performance in com-
petitive squash players.
Methods
Participants
Following local ethics approval and written informed consent,
ten competitive squash players (9 male) of county level or
above volunteered to participate in the study. One male indi-
vidual did not fully adhere to the participant preparation
guidelines and was therefore removed from all subsequent
analyses. Descriptive characteristics of the participant group
are presented in Table 1.
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General design
A double blind, crossover design was utilised whereby partici-
pants were randomly assigned to either an experimental (Cr)
or control (placebo) group. The design was counterbalanced
(i. e., an equal number of subjects started each condition) in or-
der to eliminate an order effect. After one initial familiarisation
session participants performed an on-court ªghostingº routine
pre- and post-supplementation. A 4 wk washout period sep-
arated the crossover of treatments and the ªghostingº routine
was repeated immediately prior to the crossover. All proce-
dures were conducted in accordance with ethical standards of
the Committee on Human Experimentation at the host institu-
tion and with the Helsinki Declaration of 1975. Fig.1 provides a
schematic representation of the study design.
Procedure
Participant preparation and testing environment
Each test was scheduled at a similar time of day ( 1 h) in order
to minimise the effect of diurnal fluctuation [1]. Participants
were advised not to engage in strenuous activity two days
before an exercise test and not to exercise on the day of a test.
Individuals were requested to maintain their normal diet in
the few days preceding an exercise test, to refrain from alcohol
two days before a testing session, and to avoid caffeinated
beverages on a test day. Court temperature was maintained
throughout the duration of the study, and participants were
thoroughly familiarised with test procedures prior to data col-
lection.
Body anthropometry
Body mass was measured on accurately calibrated electronic
scales (Seca Alpha 770, Birmingham, UK) to the nearest 0.1 kg,
and stature with a stadiometer (Seca 220, Birmingham, UK) re-
corded to the nearest 0.5 cm. Body density was estimated from
the sum of four skin-fold sites based on the procedures of Dur-
nin and Womersley [13], and estimated percentage body fat
was calculated using the equation of Siri [45]. Fat free mass
was calculated by subtracting fat mass from total body mass.
Maximum oxygen uptake
Participants performed a maximal incremental exercise test on
a motorised treadmill (Quinton Q65, Seattle, USA) for determi-
nation of maximum oxygen uptake (VÇ O2max). Ventilatory and
pulmonary gas exchange indices were measured breath-by-
breath using an automated on-line gas analysis system (Mijn-
hardt Oxycon Alpha, Bunnik, Holland), and VÇ O2max was de-
fined as the highest value averaged over 1min.
ªGhostingº routine
Following a standardised warm up, participants performed an
on-court ªghostingº routine, which involved 10 sets of 2 repe-
titions, each set interspersed with 30 s passive recovery
(Fig.1). Every repetition required participants to simulate po-
sitional play during a game of squash and involved the follow-
ing fake shots: front right corner forehand drop-shot (A), front
left corner backhand drop-shot (B), back left corner backhand
(C), back right corner forehand (D), right forehand volley at
head-height (E), and left backhand volley at head-height (F).
Participants were instructed to position the racquet head over
taped off areas on the court and to always place one foot
within a 0.5 m square box located over the ªTº between shots.
The on-court set-up and order of shots are illustrated in Fig. 2.
Repetition time was measured with electronic timing gates
(Eleiko Sport AB, Sweden), recovery time was measured manu-
Fig. 2 Court set-up
Fig. 1 General study design (upper panel) and exercise protocol
(lower panel).
Table 1 Descriptive and physical characteristics of the participants
Mean SEM
Gender (M/F) 8/1 -
Age (y) 21.3 0.3
Stature (m) 1.77 0.04
Body mass (kg) 73.3 3.3
Sum of 4 skinfolds (mm) 35.0 3.9
Estimated body fat (%) 15.2 1.4
Fat mass (kg) 11.2 1.2
Fat free mass (kg) 62.2 2.8
VÇO2max (L ´ min±1) 4.52 0.21
VÇO2max (ml ´ kg±1 ´ min±1) 61.9 2.1
Creatine and Squash Performance Int J Sports Med 2001; 22 547
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ally with a stopwatch, and participants were instructed to
complete each repetition in the shortest time possible. The test
was designed to elicit a set sprint time of ~ 30 s. A fatigue index
was calculated for the ghosting routine as the mean of sets 1
and 2 vs. the mean of sets 9 and 10. The within-subject coeffi-
cient of variation (CV) and intraclass correlation coefficient
(ICC) for mean set time determined for the control condition
separated by 5 days were 1.5 % and 0.88, respectively. Heart
rate (fc) was monitored throughout each trial by telemetry (Po-
lar Vantage NV, Finland) and data were analysed using appro-
priate software (Polar Precision Performance 2.0, Finland).
Blood sampling and analysis
Capillary blood was sampled from an earlobe pre- and post-
warm up, after every alternate set, and 2 min post-exercise
for subsequent determination of whole blood lactate concen-
tration ([La±]B). Blood samples were obtained using a sterile
lancet, collected in 100 ml heparinised capillary tubes, and pi-
petted into 0.5 ml micro-centrifuge tubes. The tubes were agi-
tated, immediately stored on ice (~2 8C), and analysed in dupli-
cate within 4 h of collection using an electrochemical analyser
(YSI 2300 Stat Plus, USA).
Loading regimen
The experimental and control groups supplemented 4 times
daily for 5 d with 0.075 g ´ kg±1 body mass of Cr monohydrate
and maltodextrine, respectively. This loading regimen results
in a rapid (within 20 min), marked (~1 mM increase), and sus-
tained (~3 h) rise in plasma Cr concentration [25]. Both groups
were instructed to dissolve the supplement in warm solution
and ingest in combination with simple carbohydrates [19,20].
Participants were advised to refrain from caffeinated bever-
ages [50] and allowed to exercise normally during the first
few days of supplementation [25]. Subjects reported that they
were unable to discriminate between the two interventions ei-
ther at the end of each loading period or at the end of the study.
A 4 wk washout period separated the crossover of treatments.
The natural time-course of muscle Cr decay following 5 d of
20 g ´ d±1 loading occurs over the course of 3 to 4 weeks [27].
Adverse effects
Participants were asked to rate their perceptions of cramping,
gastrointestinal distress, nausea, dizziness, and dehydration
using a 4 point Likert scale (0 = not at all, 1 = mild, 2 = moder-
ate, 3 = severe) immediately following the placebo and Cr in-
terventions. It was impressed upon participants that the sub-
jective ratings should be scored relative to normal sensations
experienced prior to the study. In addition to the perceptual
ratings, body mass was recorded following both interventions.
Data analyses
Repeated measures ANOVA was used to test for effects due to
ªtreatmentº (experimental and control), ªtimeº (pre- and
post-supplementation), ªsetº (1 to 10), and ªrepetitionº (1 and
2) on each of the dependent variables (time, [La±]B, and fc).
Mauchlys sphericity test was used to check for homogeneity
of variance and homogeneity of covariance. Violations of the
assumption of sphericity were corrected using the Green-
house-Geisser adjustment. The residuals from the ANOVA
were checked for normality. An alpha level of 0.05 was chosen
a priori to represent statistical significance. Planned pairwise
comparisons were made with repeated measures t-tests and
the Bonferroni adjustment was used to modify the per family
type I error rate per comparison. The 95 % confidence interval
was calculated for the relative change in mean set time above
the control condition from a t-distribution. Pearson product
moment correlation coefficients were computed to assess the
degree of relationship between the relative changes in body
mass and mean sprint time following Cr supplementation. Re-
sults are expressed as mean  standard error of the mean
(SEM). All statistical analyses were performed using the 8.0 re-
lease version of SPSS for Windows. (SPSS Inc, Chicago IL, USA).
Results
The ªghostingº routine elicited a marked physiological re-
sponse in participants during the pre-supplementation condi-
tion (fatigue index 5.5  1.6 %, peak [La±]B 8.0  0.5 mM, and
mean fc 176  2 beats  min±1 [89.2  0.8 % fcmax]). All experi-
mental subjects improved mean time for all 10 sprints (i. e.,
mean set sprint time) by an average of 4.7  0.3 % (31.66  0.56
vs. 30.16  0.51 s for pre- and post-Cr, respectively, range = 3.3
to 6.6 %). The control group exhibited less marked improve-
ments in mean set sprint time of 1.5  0.6% (31.51  0.36 vs.
31.04  0.34 s for pre- and post-placebo, respectively). The ex-
perimental group improved set mean sprint time by 3.2  0.8 %
over and above the changes noted for the control group
(P = 0.004; 95% CI = 1.4 to 5.1%). These changes are illustrated
in Fig. 3. Sets 2 to 10 were significantly quicker following Cr
supplementation compared to the placebo condition
(Figs. 4,5,6). Heart rate and [LA-]B were unaffected by Cr sup-
plementation (P > 0.05; Table 2).
Fig. 4 Relative change in set time for experimental and control con-
ditions. Note: *p < 0.05.
Fig. 3 Relative change in mean repetition and set time for experi-
mental and control conditions (mean  SEM). Note: **P < 0.01.
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Both control and experimental groups were found to be
asymptomatic throughout the period of intervention ± none
of the participants reported an increased incidence of cramp-
ing, gastrointestinal distress, nausea, dizziness, and/or dehy-
dration following Cr supplementation. However, a significant
1.5  1.3% gain of body mass was observed in the Cr group
(73.5  10.2 vs. 74.5  9.9 kg for pre- and post-Cr, respectively,
P = 0.03). A non-significant correlation was found between
the relative changes in body mass and mean sprint time fol-
lowing Cr supplementation (r = ±0.16; P = 0.68).
Discussion
Main findings
Repetitive sprint
To the authors knowledge, this is the first study to confirm
the potentiating effect of Cr supplementation on high intensi-
ty, intermittent exercise performance in squash players. The
results are in agreement with those from several placebo-
controlled laboratory [5,12,14,29,42,50] and field [2,3,24,28,
33,38] studies investigating the influence of Cr supplementa-
tion on repetitive sprint performance. However, the results
are contrary to the findings of other studies that were unable
to demonstrate an ergogenic effect of Cr supplementation on
repetitive sprint performance in the laboratory [4,10,11,15] or
field [6,37, 43,44,47]. Possible explanations for these discrep-
ancies may be related to individual variability in response to
Cr supplementation, insufficient time to allow washout of Cr
in crossover studies, a large inter-individual variance in exer-
cise performance coupled with a small sample size, and/or
use of exercise protocols with a greater emphasis on aerobic
versus anaerobic metabolism.
Single sprint
Although on balance it appears that repetitive sprint perform-
ance can be improved following Cr supplementation, the ques-
tion whether Cr administration improves performance in a
single bout of exercise remains controversial. On closer inspec-
tion of the data, mean time to complete repetitions 1 and 2
was not significantly different following Cr supplementation
compared to the placebo condition This finding is in agree-
ment with previous studies that have shown non-significant
improvements in single exercise bouts lasting up to 30 s fol-
lowing Cr supplementation [6,12,37, 39,46,48]. In contrast,
other studies have demonstrated a potentiating effect of Cr
supplementation on single sprint performance of similar dura-
tion [3,5,8,14,23, 24,42]. The explanation for the apparent
conflict in research findings is unclear but may stem from var-
iations in the duration of exercise used to evaluate perform-
ance.
Fig. 5 Absolute change in repetition and
set time for the experimental condition
(mean  SEM). Note: *P < 0.05.
Fig. 6 Absolute change in repetition and
set time for the control condition (mean 
SEM).
Table 2 Data for mean set blood lactate and heart rate (mean  SEM)
Cr Placebo
Pre Post Pre Post
Blood lactate (mM) 7.3  0.6 6.7  0.55 6.6  0.4 6.8  0.4
Heart rate (beatsmin-1) 174  2 173  2 177  2 176  2
Heart rate (%max) 89  1 88  1 90  1 89  2
Creatine and Squash Performance Int J Sports Med 2001; 22 549
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Critique of methods
Reliability of test
As previously mentioned, a large inter-individual variance in
exercise performance coupled with a small sample size may
partly explain why several studies have failed to demonstrate
an ergogenic effect with Cr supplementation. The small rela-
tive variability of the participant group over its distribution
on mean set time following one familiarisation trial
(CV = 1.5%) suggests that the ªghostingº routine used in the
present study can be used to reliably detect small differences
in exercise performance. Despite the dearth of data regarding
test-retest reliability of repetitive sprint performance meas-
ures, the reliability coefficient for mean set time determined
in the present study compares favourably with the results of
previous investigations. Fitzsimons et al. [17] reported ade-
quate reliability on test score for cycling (6  6 s efforts, depart-
ing every 30 s; CV = 2.5 ± 4.0 %) and running (6  40 m efforts,
departing every 30 s; CV = 1.0 ± 1.7 %) tests of repeated sprint
ability. More recently, Capriotti et al. [7] reported a mean CV
of 2.8 % for peak power achieved during a multi-sprint cycle
test (10  7 s, departing every 30 s) after two familiarisation
sessions.
An advantage of the present study over many previous field-
based studies on the ergogenic effects of Cr supplementation
is that the participant group was comprised of well-trained in-
dividuals. All participants were at least senior county level, and
three individuals were GB national standard. Indeed, VÇ O2max
for the participant group studied (61.7 ml ´ kg±1 ´ min±1) was
higher than the values reported for ªhigh levelº Canadian play-
ers (56.0 ml ´ kg±1 ´ min±1) [34] and top club South African
males (59.5 ml ´ kg±1 ´ min±1) [52], but was comparable to val-
ues reported for elite Asian (61.7 ml ´ kg±1 ´ min±1) [9] and Irish
(63.3 ml ´ kg±1 ´ min±1) [49] males. The well-trained nature of
the participant group might have enabled those individuals to
pace themselves more reproducibly during the ªghostingº rou-
tine, perhaps because their perceptions of effort or fatigue that
limit performance were less variable. Likewise, all participants
were accustomed to performing ªghostingº routines during
normal training, which would likely improve further the relia-
bility of performance measures.
Specificity of test
The performance test used in the present study was chosen on
the basis that: 1) time and motion analyses of squash games
during actual competition have consistently revealed a 1:1
work to rest ratio [36], 2) for top level players a small but im-
portant 20% of rallies last more than 20 s with 8 % lasting more
than 30 s [36], 3) ªshadowº or ªghostingº interval regimens,
similar to the one used in the present study, are an effective
anaerobic glycolytic training stimulus commonly used by
squash players [44]; and 4) the routine elicits a marked phys-
iological response similar to that encountered during competi-
tive match play. Indeed, peak blood lactate recorded after the
final repetition was 8.0 mM, which compares favourably with
peak lactate values reported for actual match play in highly
skilled individuals playing against an opponent of equal ability
(8.0 mM) [34]. Furthermore, heart rate averaged 89 % of maxi-
mum, which is comparable to the mean heart rate typically
maintained throughout a match (80 to 90% fcmax) [36].
Functional relevance of test
Although this study identified a significant 3.2 % effect in
repetitive sprint performance above control conditions (and
the 95 % confidence interval for this outcome included an en-
hancement of almost twice this magnitude), we are unable to
determine the precise influence this improvement might have
on actual match performance. We speculate that improve-
ments in actual match performance will be even more marked.
For professional and ªgrade Aº players 80% of rallies last less
than 20 s and 49 % last 10 s or less, and the average match (best
of five games) may last from 30 to 90 min [36] up to a maxi-
mum of 2 h 45 min [44]. The cumulative effect of shorter ral-
lies, which are more reliant on the ATP-PCR energy system,
performed over a longer time period would be likely to chal-
lenge the immediate energy system more than in the present
study. Future studies might consider investigating the effects
of Cr supplementation on exercise performance by using sim-
ulated match play to mimic the physiological demands of high
level squash, and utilise an outcome measure that has appro-
priate external validity, for example, shot accuracy.
Potential mechanisms
The precise mechanism by which Cr achieves its acute ergo-
genic effect is not yet clear. Research to date suggests that it
may be related to increased availability of pre-exercise PCr,
particularly in Type II muscle fibres [8]. In addition, Cr supple-
mentation has been reported to accelerate post exercise PCr
resynthesis [22]. Collectively, these mechanisms would be ex-
pected to maintain ATP turnover during exercise and increase
muscle contractile capability. Support for this suggestion orig-
inates from maximal exercise studies demonstrating attenu-
ated adenine nucleotide degradation (as measured by the ac-
cumulation of plasma ammonia and hypoxanthine) following
Cr supplementation, despite the completion of more work
[2, 5,23]. More direct evidence stems from the finding that
the reduction in muscle ATP during maximal isokinetic cycling
exercise was attenuated by -30 % following Cr supplementa-
tion, despite a higher work output [8]. However, more recently
it was found that Cr supplementation did not facilitate muscle
PCr resynthesis during intermittent isometric muscle contrac-
tions, despite raising skeletal muscle PCr concentrations and
improving performance during rapid and dynamic intermit-
tent muscle contractions [51]. Moreover, higher pre-exercise
concentrations of PCr at rest compensated for significantly
slower recovery rates of PCr after Cr supplementation [32].
Collectively, these studies oppose the notion of increased PCr
resynthesis and support the idea of higher starting levels of
PCr.
Based on findings of lowered post-exercise lactate concentra-
tions some authors have suggested that the resynthesis of
ATP during high-intensity exercise would rely less on anaero-
bic glycolysis following oral Cr supplementation [2,29]. This
would presumably attenuate the decrease in intramuscular
pH and enhance resistance to fatigue. Nevertheless, the non-
significant change in exercise blood lactate concentration ob-
served in the present study suggests that a reduced metabolic
acidosis was not the principal mechanism for improvement in
exercise performance following Cr supplementation. This find-
ing is in agreement with previous research, which have shown
unchanged post-exercise lactate concentrations following Cr
Int J Sports Med 2001; 22 Romer LM et al550
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supplementation [5,6,8,15,22,23, 37]. Interestingly, blood lac-
tate measured 2 min post-exercise was significantly lower
than the value obtained immediately after the final repetition
(7.2  0.5 vs. 8.0  0.5 mM, respectively). Rapid clearance of lac-
tate following high intensity exercise is an important compo-
nent of squash fitness, particularly given the marked metabolic
consequences of the game, and is presumably a function of lac-
tate uptake by both active and inactive muscle fibres and other
gluconeogenic tissues.
Adverse effects
Individuals in the present study did not experience an in-
creased prevalence of cramping, gastrointestinal distress, nau-
sea, dizziness, or dehydration throughout the duration of
study compared to baseline values. Anecdotal reports of ad-
verse side effects following Cr ingestion are largely unsupport-
ed by the scientific literature. To date, no peer-reviewed stud-
ies have reported an increased prevalence of cramping follow-
ing Cr supplementation, and acute Cr supplementation
(20 g ´ d±1 for 5 d) does not appear to adversely affect renal
function in healthy individuals [40]. However, participants in
the present study did experience a significant 1.0 kg (1.4 %) in-
crease in body mass following Cr supplementation. This in-
crease was of magnitude similar to that reported by other in-
vestigators (0.5 to 2.0 kg) [31] and is probably the result of in-
creased water retention representing the need for the muscle
to dilute the increased concentration of solute in the muscle
to maintain osmotic gradients and hydration status [31]. Al-
though an increase in body mass might be expected to hinder
exercise performance in a weight bearing sport such as squash,
the non-significant correlation between relative changes in
body mass and exercise performance does not lend support to
this contention. Data concerning the potential adverse effects
of chronic Cr supplementation are limited, although a recent
controlled study suggests that long-term Cr supplementation
(10 g ´ d±1 for 5 years and 30 g ´ d±1 for one year) in healthy
adults poses no threat to normal physiological function [41].
In conclusion, these data support existing evidence that Cr
supplementation improves high intensity, intermittent exer-
cise performance. In addition, the present study provides new
evidence that oral Cr supplementation improves exercise per-
formance in competitive squash players.
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